Morphosys jumps as FDA approves psoriasis drug

loading...


Morphosys jumps as FDA approves psoriasis drug
FRANKFURT (Reuters) – Shares in Morphosys jumped 9 percent on Friday after a licensee won U.S. approval for psoriasis drug guselkumab, bringing the German biotech group a step closer to launching its first antibody drug on to the market.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...